PLANTS HAVING INCREASED RESISTANCE TO PLANT PATHOGENS, AND METHOD FOR CREATING INCREASED PATHOGEN RESISTANCE IN PLANTS
20170306350 · 2017-10-26
Assignee
Inventors
- GABRIEL SCHAAF (Tübingen, DE)
- DEBABRATA LAHA (Tübingen, DE)
- MARC FREYER (Dettenhausen, DE)
- MARÍLIA K.F. DE CAMPOS (Tübingen, DE)
- PHILIPP JOHNEN (Tübingen, DE)
- SASKIA C.M. VAN WEES (MAARSSEN, NL)
Cpc classification
C12N15/8279
CHEMISTRY; METALLURGY
C12N15/8245
CHEMISTRY; METALLURGY
Y02A40/146
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
C12N15/8225
CHEMISTRY; METALLURGY
International classification
Abstract
The invention relates to plants with increased resistance to plant pathogens, wherein the intracellular concentration of inositol pyrophosphate InsP.sub.7 and/or InsP.sub.8 in said plants is increased in comparison to the wild-type plant. In particular, the invention involves plants with increased expression of at least one protein involved in the synthesis of inositol pyrophosphates InsP.sub.7 and/or InsP.sub.8, such as, for example, proteins VIH2 and VIH1. The plants according to the invention are particularly resistant to the following plant pathogens: herbivore insects, for example larvae of agriculturally relevant pests, pathogenic fungi, such as necrotrophic fungi, or other plant pests, such as biotrophic pathogens. The invention further relates to the method for increasing plant resistance to plant pathogens, wherein the intracellular concentration of inositol pyrophosphates InsP.sub.7 and/or InsP.sub.8 is increased in comparison to the wild-type plant.
Claims
1. A plant with increased resistance to plant pathogens, in which the intracellular concentration of inositol pyrophosphates InsP.sub.7 and/or InsP.sub.8 is increased in comparison with the wildtype plant.
2. The plant as claimed in claim 1, having inducible or increased expression of at least one protein involved in the synthesis of inositol pyrophosphates InsP.sub.7 and/or InsP.sub.8.
3. The plant as claimed in claim 1, wherein the expression and/or the activity of a protein selected from the group consisting of VIH2 encoded by a nucleotide sequence 2 (GenBank Accession: At3g01310), VIH1 encoded by a nucleotide sequence 1 (GenBank Accession: At5g15070), and a homologous protein capable of synthesizing inositol pyrophosphates InsP.sub.7 and/or InsP.sub.8, is in the whole plant or in specific tissues inducible, or is increased in comparison with the wildtypes.
4. (canceled)
5. The plant according to claim 3, in which the nucleotide sequence 1 or the nucleotide sequence 2 originates from the same plant species or from a different organism.
6. The plant according to claim 3, wherein the nucleotide sequence 1 or the nucleotide sequence 2 is under the control of a promoter that is selected from the group consisting of an inducible promoter and a constitutive promoter.
7. (canceled)
8. The plant according to claim 6, wherein the promoter is tissue-specific, for example leaf-, fruit- or seed-specific.
9. The plant according to claim 1, wherein the plant pathogens are herbivorous insects, for example larvae of agriculturally relevant pests, such as the small cabbage white or the owlet moth, or pathogenic fungi, such as necrotrophic fungi, for example, representatives of the genera Alternaria or Botrytis, or other plant pests, including biotrophic pathogens.
10. A method for increasing plant resistance against plant pathogens, wherein the intracellular concentration of inositol pyrophosphates InsP.sub.7 and/or InsP.sub.8 is increased in comparison to the wildtype plant.
11. The method according to claim 10, wherein the plants are treated with InsP.sub.7, with InsP.sub.8 and/or with InsP.sub.7 or InsP.sub.8 derivatives, for example in form of sprinkling, spraying or the like.
12. The method according to claim 11, wherein the derivatives are membrane permeable esters.
13. The plant as claimed in claim 2, wherein the expression and/or the activity of a protein selected from the group consisting of VIH2 encoded by a nucleotide sequence 2 (GenBank Accession: At3g01310), VIH1 encoded by a nucleotide sequence 1 (GenBank Accession: At5g15070), and a homologous protein capable of synthesizing inositol pyrophosphates InsP.sub.7 and/or InsP.sub.8, is in the whole plant or in specific tissues inducible, or is increased in comparison with the wildtypes.
14. The plant according to claim 13, in which the nucleotide sequence 1 or the nucleotide sequence 2 originates from the same plant species or from a different organism.
15. The plant according to claim 13, wherein the nucleotide sequence 1 or the nucleotide sequence 2 is under the control of a promoter that is selected from the group consisting of an inducible promoter and a constitutive promoter.
16. The plant according to claim 14, wherein the nucleotide sequence 1 or the nucleotide sequence 2 is under the control of a promoter that is selected from the group consisting of an inducible promoter and a constitutive promoter.
17. The plant according to claim 15, wherein the promoter is tissue-specific, for example leaf-, fruit- or seed-specific.
18. The plant according to claim 16, wherein the promoter is tissue-specific, for example leaf-, fruit- or seed-specific.
19. The plant according to claim 2, wherein the plant pathogens are herbivorous insects, for example larvae of agriculturally relevant pests, such as the small cabbage white or the owlet moth, or pathogenic fungi, such as necrotrophic fungi, for example, representatives of the genera Alternaria or Botrytis, or other plant pests, including biotrophic pathogens.
20. The plant according to claim 3, wherein the plant pathogens are herbivorous insects, for example larvae of agriculturally relevant pests, such as the small cabbage white or the owlet moth, or pathogenic fungi, such as necrotrophic fungi, for example, representatives of the genera Alternaria or Botrytis, or other plant pests, including biotrophic pathogens.
Description
[0026] Further advantages, features and possible applications of the invention are described in the following with reference to the below described exemplary embodiment referring to the figures.
[0027]
[0028]
[0029]
[0030]
[0031]
EXEMPLARY EMBODIMENTS
[0032] The experiments were performed with isogenic lines of the same ecotype (Arabiopsis thaliana, Col-0), which are characterized by presence (Col-0) and absence (vih2-3 and vih2-4) of an intact VIH2 gene (and thus VIH2 protein), or by increased expression of the VIH2 kinase domain (CaMV 35S: VIH2). In the latter plants (CaMV 35S: VIH2), the kinase domain of the wild-type VIH2 gene was under the control of the strong viral CaMV 35S promoter. For this purpose, the VIH2 kinase sequence was amplified by an Arabidopsis cDNA and inserted into the vector pENTR™/D-TOPO® (Invitrogen Life Technologies). From there the VIH2 kinase domain sequence was transferred by Gateway® LR Clonase™ II (Invitrogen Life Technologies) into the binary plant transformation vector pGWB441 (Nakagawa et al., 2007, Biosci. Biotechnol. Biochem, 71, 2095-2100). The vector produced thereby “pGWB441-VIH2 KD” was used for the transformation of Arabidopsis plants. Several independent transformants were selected on kanamycin, no longer segregating CaMV 35S: VIH2 T3 plants were established and an increased InsP.sub.8 biosynthesis was confirmed in these plants.
[0033] The exemplary embodiments indicate that VIH2 loss of function mutants have reduced resistance to herbivorous insects and nectrotrophic fungi (
REFERENCES
[0034] 1. Dean R, Van Kan J A, Pretorius Z A, Hammond-Kosack K E, Di Pietro A, Spanu P D, et al. The top 10 fungal pathogens in molecular plant pathology. Mol Plant Pathol 2012, 13 (4): 414-430. [0035] 2. Dakin K, Li W H. Cell membrane permeable esters of D-myo-inositol 1, 4,5-trisphosphates. Cell calcium 2007, 42 (3): 291-301. [0036] 3. Kemmerling B, Schwedt A, Rodriguez P, Mazzotta S, Frank M, Abu Qamar S, et al. The BRIT-associated kinase 1, BAK1, has a Brassinoli-independent role in plant cell death control. Current Biology, 2007, 17 (13): 1116-1122. [0037] 4. Submit Corrections Close Van Wees S C, Van Pelt J A, Bakker P A, Pieterse C M. Bioassays for assessing jasmonate-dependent defenses triggered by pathogens, herbivorous insects, or beneficial rhizobacteria. Methods Mol Biol 2013, 1011: 35-49.